A modified HSV-1 oncolytic virus reconciles antiviral and antitumor immunity via promoting IFNβ expression and inhibiting PKR
Yangkun Shen, Xiangqian Zhao, Lizhu Chen, Xin Wang, Dawei Wang, Hucheng Zhang, Zuda Zheng, Weiwei Huang, Chunfu Zheng, Yu Chen, Chuanben Chen, Qi Chen
Topics & Concepts
Oncolytic virusBiologyInterferonCD8ImmunotherapyImmune systemImmunityInnate immune systemCancer researchT cellVirologyImmunologyVirus-based gene therapy researchViral gastroenteritis research and epidemiologyAnimal Virus Infections Studies